Cargando…

Visual reading for [(18)F]Florzolotau ([(18)F]APN-1607) tau PET imaging in clinical assessment of Alzheimer’s disease

INTRODUCTION: Tau-targeted positron emission tomography (tau-PET) is a potential tool for the differential diagnosis of Alzheimer’s disease (AD) and to clarify the distribution of tau deposition. In addition to the quantitative analysis of tau-PET scans, visual reading supports the assessment of tau...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Huan-Chun, Lin, Kun-Ju, Huang, Kuo-Lun, Chen, Shih-Hsin, Ho, Tsung-Ying, Huang, Chin-Chang, Hsu, Jung-Lung, Chang, Chiung-Chih, Hsiao, Ing-Tsung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213356/
https://www.ncbi.nlm.nih.gov/pubmed/37250400
http://dx.doi.org/10.3389/fnins.2023.1148054
_version_ 1785047603047563264
author Lin, Huan-Chun
Lin, Kun-Ju
Huang, Kuo-Lun
Chen, Shih-Hsin
Ho, Tsung-Ying
Huang, Chin-Chang
Hsu, Jung-Lung
Chang, Chiung-Chih
Hsiao, Ing-Tsung
author_facet Lin, Huan-Chun
Lin, Kun-Ju
Huang, Kuo-Lun
Chen, Shih-Hsin
Ho, Tsung-Ying
Huang, Chin-Chang
Hsu, Jung-Lung
Chang, Chiung-Chih
Hsiao, Ing-Tsung
author_sort Lin, Huan-Chun
collection PubMed
description INTRODUCTION: Tau-targeted positron emission tomography (tau-PET) is a potential tool for the differential diagnosis of Alzheimer’s disease (AD) and to clarify the distribution of tau deposition. In addition to the quantitative analysis of tau-PET scans, visual reading supports the assessment of tau loading for clinical diagnosis. This study aimed to propose a method for visually interpreting tau-PET using the [(18)F] Florzolotau tracer and investigate the performance and utility of the visual reading. MATERIALS AND METHODS: A total number of 46 individuals with 12 cognitively unimpaired subjects (CU), 20 AD patients with mild cognitive impairment (AD-MCI), and 14 AD with dementia (AD-D) patients with both [(18)F]Florbetapir amyloid PET and [(18)F]Florzolotau tau PET scans were included. Clinical information, cognitive assessment, and amyloid PET scan results were recorded. For visual interpretation, a modified rainbow colormap was created and a regional tau uptake scoring system was proposed to evaluate the degree of tracer uptake and its spatial distribution within five cortical regions. Each region was scored on a scale of [0, 2] as compared to the background, and that resulted in a global scale range of [0, 10]. Four readers interpreted [(18)F]Florzolotau PET using the visual scale. The global and regional standardized uptake value ratios (SUVr) were also calculated for analysis. RESULTS: The result indicates the average global visual scores were 0 ± 0 in the CU group, 3.43 ± 3.35 in the AD-MCI group, and 6.31 ± 2.97 in the AD-D group (p < 0.001). The consensus among the four observers on image scores was high with an intraclass correlation coefficient of 0.880 (95% CI: 0.767–0.936). The average global visual score was significantly associated with global SUVr (r = 0.884, p < 0.0001) and with the CDR-sum of box (r = 0.677, p < 0.0001). CONCLUSION: The visual reading method generated a visual score of [(18)F]Florzolotau tau-PET with good sensitivity and specificity to identify AD-D or CU individuals from the other patients. The preliminary result also showed that the global visual scores are significantly and reliably correlated with global cortical SUVr, and associated well with the clinical diagnosis and cognitive performance.
format Online
Article
Text
id pubmed-10213356
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-102133562023-05-27 Visual reading for [(18)F]Florzolotau ([(18)F]APN-1607) tau PET imaging in clinical assessment of Alzheimer’s disease Lin, Huan-Chun Lin, Kun-Ju Huang, Kuo-Lun Chen, Shih-Hsin Ho, Tsung-Ying Huang, Chin-Chang Hsu, Jung-Lung Chang, Chiung-Chih Hsiao, Ing-Tsung Front Neurosci Neuroscience INTRODUCTION: Tau-targeted positron emission tomography (tau-PET) is a potential tool for the differential diagnosis of Alzheimer’s disease (AD) and to clarify the distribution of tau deposition. In addition to the quantitative analysis of tau-PET scans, visual reading supports the assessment of tau loading for clinical diagnosis. This study aimed to propose a method for visually interpreting tau-PET using the [(18)F] Florzolotau tracer and investigate the performance and utility of the visual reading. MATERIALS AND METHODS: A total number of 46 individuals with 12 cognitively unimpaired subjects (CU), 20 AD patients with mild cognitive impairment (AD-MCI), and 14 AD with dementia (AD-D) patients with both [(18)F]Florbetapir amyloid PET and [(18)F]Florzolotau tau PET scans were included. Clinical information, cognitive assessment, and amyloid PET scan results were recorded. For visual interpretation, a modified rainbow colormap was created and a regional tau uptake scoring system was proposed to evaluate the degree of tracer uptake and its spatial distribution within five cortical regions. Each region was scored on a scale of [0, 2] as compared to the background, and that resulted in a global scale range of [0, 10]. Four readers interpreted [(18)F]Florzolotau PET using the visual scale. The global and regional standardized uptake value ratios (SUVr) were also calculated for analysis. RESULTS: The result indicates the average global visual scores were 0 ± 0 in the CU group, 3.43 ± 3.35 in the AD-MCI group, and 6.31 ± 2.97 in the AD-D group (p < 0.001). The consensus among the four observers on image scores was high with an intraclass correlation coefficient of 0.880 (95% CI: 0.767–0.936). The average global visual score was significantly associated with global SUVr (r = 0.884, p < 0.0001) and with the CDR-sum of box (r = 0.677, p < 0.0001). CONCLUSION: The visual reading method generated a visual score of [(18)F]Florzolotau tau-PET with good sensitivity and specificity to identify AD-D or CU individuals from the other patients. The preliminary result also showed that the global visual scores are significantly and reliably correlated with global cortical SUVr, and associated well with the clinical diagnosis and cognitive performance. Frontiers Media S.A. 2023-05-12 /pmc/articles/PMC10213356/ /pubmed/37250400 http://dx.doi.org/10.3389/fnins.2023.1148054 Text en Copyright © 2023 Lin, Lin, Huang, Chen, Ho, Huang, Hsu, Chang and Hsiao. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Lin, Huan-Chun
Lin, Kun-Ju
Huang, Kuo-Lun
Chen, Shih-Hsin
Ho, Tsung-Ying
Huang, Chin-Chang
Hsu, Jung-Lung
Chang, Chiung-Chih
Hsiao, Ing-Tsung
Visual reading for [(18)F]Florzolotau ([(18)F]APN-1607) tau PET imaging in clinical assessment of Alzheimer’s disease
title Visual reading for [(18)F]Florzolotau ([(18)F]APN-1607) tau PET imaging in clinical assessment of Alzheimer’s disease
title_full Visual reading for [(18)F]Florzolotau ([(18)F]APN-1607) tau PET imaging in clinical assessment of Alzheimer’s disease
title_fullStr Visual reading for [(18)F]Florzolotau ([(18)F]APN-1607) tau PET imaging in clinical assessment of Alzheimer’s disease
title_full_unstemmed Visual reading for [(18)F]Florzolotau ([(18)F]APN-1607) tau PET imaging in clinical assessment of Alzheimer’s disease
title_short Visual reading for [(18)F]Florzolotau ([(18)F]APN-1607) tau PET imaging in clinical assessment of Alzheimer’s disease
title_sort visual reading for [(18)f]florzolotau ([(18)f]apn-1607) tau pet imaging in clinical assessment of alzheimer’s disease
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213356/
https://www.ncbi.nlm.nih.gov/pubmed/37250400
http://dx.doi.org/10.3389/fnins.2023.1148054
work_keys_str_mv AT linhuanchun visualreadingfor18fflorzolotau18fapn1607taupetimaginginclinicalassessmentofalzheimersdisease
AT linkunju visualreadingfor18fflorzolotau18fapn1607taupetimaginginclinicalassessmentofalzheimersdisease
AT huangkuolun visualreadingfor18fflorzolotau18fapn1607taupetimaginginclinicalassessmentofalzheimersdisease
AT chenshihhsin visualreadingfor18fflorzolotau18fapn1607taupetimaginginclinicalassessmentofalzheimersdisease
AT hotsungying visualreadingfor18fflorzolotau18fapn1607taupetimaginginclinicalassessmentofalzheimersdisease
AT huangchinchang visualreadingfor18fflorzolotau18fapn1607taupetimaginginclinicalassessmentofalzheimersdisease
AT hsujunglung visualreadingfor18fflorzolotau18fapn1607taupetimaginginclinicalassessmentofalzheimersdisease
AT changchiungchih visualreadingfor18fflorzolotau18fapn1607taupetimaginginclinicalassessmentofalzheimersdisease
AT hsiaoingtsung visualreadingfor18fflorzolotau18fapn1607taupetimaginginclinicalassessmentofalzheimersdisease